This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.
I've re-done the first sentence by adding "Ipracetin" which is stated by Erowid.org as alternative name, and deleting "4-Ace" which was unsourced, and could be applied to any of the "4-Acetoxy" tryptamines. I don't know if it would be necessary for "Ipracetin" to be cited with a reference, but feel free to add it with the link I've already provided.--Astavats 03:40, 9 November 2007 (UTC)
This article needs a new structure image--ChemSpiderMan (talk) 06:04, 23 January 2008 (UTC)
You're right, I just noticed the missing nitrogen. I can draw a new one if needed, but I don't know how to add/replace. Just a suggestion.--Astavats (talk) 00:08, 24 January 2008 (UTC)
Replaced. -- Ed (Edgar181) 20:35, 24 January 2008 (UTC)
Nice, the new molecule looks clean, but the CAS number you added doesn't seem to be correct. It says "No term found." - take a look at it.--Astavats (talk) 01:03, 26 January 2008 (UTC)
The CAS number is correct. The database the link automatically goes to just doesn't have a record for every chemical compound with CAS number. 11:44, 25 January 2008 (UTC)
Oh I see, never mind then.--Astavats (talk) 01:03, 26 January 2008 (UTC)
There is a discussion going on about CAS over here. Making a link between the CAS number and MeSH to provide a page with no information seems of little value. Why do it?--ChemSpiderMan (talk) 14:55, 26 January 2008 (UTC)
The following discussion is an archived discussion of a requested move. Please do not modify it. Subsequent comments should be made in a new section on the talk page. No further edits should be made to this section.
The result of the move request was: page moved. Kai445 (talk) 05:26, 10 December 2011 (UTC)
The above discussion is preserved as an archive of a requested move. Please do not modify it. Subsequent comments should be made in a new section on this talk page. No further edits should be made to this section.